Sanofi in closure of $11.6 billion hemophilia specialist buy
Sanofi’s waiting period to complete the purchase of Bioverativ has came to an end, and will thus expand its hemophilia and other…
Pharmaceuticals, Biotechnology and Life Sciences
Sanofi’s waiting period to complete the purchase of Bioverativ has came to an end, and will thus expand its hemophilia and other…
Gilead Sciences will begin a search for new Commercial Operation Executive Vice President in the coming weeks’s, as its current…
Allergan and Medicines360, a global nonprofit women’s health pharmaceutical company dedicated to expanding access to quality medicines, have announced that…
World’s largest HIV/AIDS drug-maker Mylan has received tentative approval for combination HIV treatment DTG/FTC/TAF under FDA’s PEPFAR program, the company…
Novo Nordisk has completed the first phase 3a trial, PIONEER 1, with oral semaglutide, for treating type 2 diabetes in…
Novartis has announced the publication of the CLAIM study in the Lancet Respiratory Medicine, which demonstrated that treatment once-daily Ultibro…
Vertex Pharmaceuticals wants to submit a New Drug Application in the USA, so it will soon give the final test…
BASF Corporation is introducing Hepaxa, a product that can help tens of millions of patients manage Non-Alcoholic Fatty Liver Disease…
STA Pharmaceutical, a WuXi AppTec group company has entered into a deal with Regulus Therapeutics, an oligonucleotide synthesis collaboration agreement…
Celgene expects the transaction for Juno Therapeutics shares, to close in the first quarter of 2018. The company has said Wednesday…